Race, Post-Race
Rx15 tpp wed_1115_1_zhou_2fisher_3skinner
Controlled Substance Monitoring Database Prescription Drug Abuse Prevention Conference September 19, 2014 Andrew Holt, PharmD. Controlled Substance Monitoring.
2 nd Cancer Pain Symposium Opiate Related Side Effects: Focus on Constipation Lydia Mis, PharmD, BCOP Clinical Oncology Pharmacist June 6, 2008 Duke University.
PRESCRIPTION DRUG PROBLEMS IN TASMANIA, AUSTRALIA APSAD Conference 14 November 2011 Clinical Director, Alcohol & Drug Services, Tasmania Dr Adrian Reynolds.
1 Towards Successful Treatment Completion A good practice guide Dr John Dunn Consultant Psychiatrist and NTA Clinical Team Leader Effective treatment,
Notes to Slide Presenters: This presentation is for support staff to use with patients and their caregivers at the time of opioid prescribing. It should.
Prescription Behavior Surveillance Using PDMP Data
Neonatal Abstinence Syndrome in Tennessee
Case study: Market Overview of Opioids | Blueocean MI
Prescription opioid overdose & misuse in Oregon Lisa Millet, MSH Center for Prevention and Health Promotion Oregon Health Authority Governor’s Workgroup.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
